Negara: Malaysia
Bahasa: Inggris
Sumber: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
SODIUM POLYSTYRENE SULPHONATE
THE ZYFAS MEDICAL CO.,
SODIUM POLYSTYRENE SULPHONATE
1Units Units
LABS RUBIO S.A
RESINSODIO POWDER Sodium polystyrene sulphonate FORMULA PER 100 G Polystyrene sodium sulphonate (I.N.N.) 99.75 g Excipients (Vanilla essence) q.s. DESCRIPTION: White 650 cc jar (multidose container) provided with antitampering stopper containing brown or gilded fine powder, vanillin flavoured. There is also a dosing teaspoon together. PHARMACOLOGY (SUMMARY OF PHARMACODYNAMICS AND PHARMACOKINETICS The cation-exchange resin, sodium polystyrene sulphonate, is not absorbed in the gastro-intestinal tract. Gastrointestinal fluids do not affect it. Thus RESINSODIO® exchanges sodium ions for potassium ions in the colon while the resin is unchanging. The resin is finally excreted in the faeces. Sodium polystyrene sulphonate is a cation-exchange resin, which exchanges its sodium ions for potassium ions. This exchange occurs in the intestine by an osmotic process. Thus it can be understood that in the organism, via the administration of this resin and its elimination in the feces, it removes the potassium that it carries, until the plasma level reaches that which is believed to be convenient. The efficacy depends on time and potassium ions concentration. INDICATIONS RESINSODIO powder for oral suspension is indicated in the treatment and prevention of hyperkalaemia CONTRAINDICATIONS Administration should be stopped when the serum potassium level falls to 5mmol/L.Resinsodio cannot be used in patients with obstructive bowel disease. - Hypersensitivity to polystyrene sulphonate resins; - High sodium blood levels; - Neonates - Severe hypertension OVERDOSE AND TREATMENT In the event of overdosage, the resin should be removed from the alimentary tract by the use of laxatives or enemas and appropriate measures taken to restore potassium levels to normal. Overdosage may produce serious potassium deficiency and signs and symptoms have to be treated as hypokalaemia. If any other adverse reaction not previously described is observed, consult your doctor or pharmacist. WARNING AND PRECAUTIONS Sodium polystyrene sulfonate may bind orall Baca dokumen lengkapnya